Oncology & Cancer

Immunotherapy delays disease progression of high-grade meningiomas

Meningiomas, tumors of the membranes (meninges) surrounding the brain and spinal cord, are the most common tumors of the central nervous system. Although most meningiomas are low grade and cause few or no symptoms, a subset, ...

Parkinson's & Movement disorders

Scientists uncover new targets for treating Parkinson's disease

Scientists at La Jolla Institute for Immunology (LJI) have found that people with Parkinson's disease have a clear "genetic signature" of the disease in their memory T cells. The scientists hope that targeting these genes ...

Oncology & Cancer

Sequencing study unlocks mystery of multiple myeloma

In 1873, Russian doctor J. von Rusitzky coined the term "multiple myeloma" after finding eight different types of bone marrow tumors in a single patient. Nearly 150 years later, using advanced cell sequencing technology and ...

page 13 from 40